Evidence map›Paper›PMID 41108402›Full record

ReviewRadiation and environmental biophysics2025

Contributions of the radonorm project to European and international radiation protection research.

Warren John, Mandy Birschwilks, Laureline Février, Balázs Madas, Jonne Naarala, Valtteri Nieminen, Aleš Froňka, Tanja Perko, Andrzej Wojcik, Nadja Železnik

Abstract readReview
In one paragraph

Review in Radiation and environmental biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Warren JohnFederal Office for Radiation Protection, BfS, Ingolstaedter Landstrasse 1 , 85764, Oberschleissheim, Germany.ORCID 0000-0003-2150-8711
Mandy BirschwilksFederal Office for Radiation Protection, BfS, Ingolstaedter Landstrasse 1 , 85764, Oberschleissheim, Germany. mbirschwilks@bfs.de.ORCID 0000-0003-1630-9910
Laureline FévrierAutorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-ENV/SPDR/LT2S, Saint-Paul-lez-Durance, F-13115, France.ORCID 0000-0002-5274-6846
Balázs MadasHUN-REN Center for Energy Research, Konkoly-Thege Miklós út 29-33, 1121, Budapest, Hungary.ORCID 0000-0002-0698-4982
Jonne NaaralaDepartment of Environmental and Biological Sciences, University of Eastern Finland, Yliopistonranta 8, Kuopio, 70210, Finland.ORCID 0000-0002-5240-968X
Valtteri NieminenDepartment of Environmental and Biological Sciences, University of Eastern Finland, Yliopistonranta 8, Kuopio, 70210, Finland.ORCID 0000-0003-2954-7782
Aleš FroňkaNational Radiation Protection Institute, SURO, Bartoškova 1450/28 4-Nusle, 140 00, Praha, Czech Republic.ORCID 0009-0006-4348-6292
Tanja PerkoBelgian Nuclear Research Center, SCK CEN, Boeretang 200, Mol, 2400, Belgium.ORCID 0000-0001-8405-6631
Andrzej WojcikStockholm University, Frescativägen, Stockholm, 114 19, Sweden.ORCID 0000-0002-3951-774X
Nadja ŽeleznikElektroinštitut Milan Vidmar, Hajdrihova ulica 2, 1000, Ljubljana, Slovenia.ORCID 0000-0002-2096-8292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RadoNorm has come a long way since its inception, in addressing and managing risks for radon and NORM. The output of the project has been substantial in generating new findings and developing novel methodologies and tools. At the same time, the project has been translating its results into recommendations, which have been published as deliverables and scientific publications, and communicated to various stakeholders through its annual meetings, monthly webinars and the most recent RadoNorm Showcase Meeting held in Brussels. This review aims to produce a comprehensive summary of RadoNorm results and recommendations until this point (June 2025) as well as the recent discussions at the RadoNorm Showcase Meeting in March 2025, where the results were presented to a variety of stakeholders including the radiation research platforms. The results are presented under the themes of "health effects and risks", "exposure and mitigation" and "risk communication and societal aspects". RadoNorm has performed a comprehensive assessment of what has been achieved and what future questions have arisen from the latest results of the project, which are also elaborated upon herein and addressed as challenges for the European radiation research platforms to assimilate into their research portfolios.

Indexed as

Radiation ProtectionRadonEuropeHumansResearchRadonEURATOMNaturally occurring radionuclidesRadiation protectionRadiation researchRadonRadoNorm

Identifiers

PMID41108402
PMCPMC12701043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.